{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T19:42:42Z","timestamp":1775504562369,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2261-14-192","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T06:56:49Z","timestamp":1434610609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Proprotein convertase subtilisin\/kexin type 9 expression is transiently up-regulated in the acute period of myocardial infarction in rat"],"prefix":"10.1186","volume":"14","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Xia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,17]]},"reference":[{"key":"834_CR1","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.atherosclerosis.2011.04.018","volume":"216","author":"B Cariou","year":"2011","unstructured":"Cariou B, May CL, Costet P: Clinical aspects of PCSK9. Atherosclerosis. 2011, 216: 258-265. 10.1016\/j.atherosclerosis.2011.04.018.","journal-title":"Atherosclerosis"},{"key":"834_CR2","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.atherosclerosis.2007.07.022","volume":"196","author":"VM Homer","year":"2008","unstructured":"Homer VM, Marais AD, Charlton F, Laurie AD, Hurndell N, Scott R, Mangili F, Sullivan DR, Barter PJ, Rye KA, George PM, Lambert G: Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa. Atherosclerosis. 2008, 196: 659-666. 10.1016\/j.atherosclerosis.2007.07.022.","journal-title":"Atherosclerosis"},{"key":"834_CR3","first-page":"901","volume":"59","author":"NQ Wu","year":"2013","unstructured":"Wu NQ, Guo YL, Xu RX, Liu J, Zhu CG, Jiang LX, Li JJ: Acute myocardial infarction in an 8-year old male child with homozygous familiar hypercholesterolemia: laboratory findings and response to lipid-lowering drugs. Clin Lab. 2013, 59: 901-907.","journal-title":"Clin Lab"},{"key":"834_CR4","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1210\/jc.2012-1563","volume":"97","author":"M Benn","year":"2012","unstructured":"Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG: Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab. 2012, 97: 3956-3964. 10.1210\/jc.2012-1563.","journal-title":"J Clin Endocrinol Metab"},{"key":"834_CR5","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.111.057406","volume":"125","author":"M Denis","year":"2012","unstructured":"Denis M, Marcinkiewicz J, Zaid A, Gauthier D, Poirier S, Lazure C, Seidah NG, Prat A: Gene Inactivation of proprotein convertase subtilisin\/kexin type 9 reduces atherosclerosis in mice. Circulation. 2012, 125: 894-901. 10.1161\/CIRCULATIONAHA.111.057406.","journal-title":"Circulation"},{"key":"834_CR6","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1056\/NEJMoa054013","volume":"354","author":"JC Cohen","year":"2006","unstructured":"Cohen JC, Boerwinkle E, Mosley TH, Hobbs HH: Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006, 354: 1264-1272. 10.1056\/NEJMoa054013.","journal-title":"N Engl J Med"},{"key":"834_CR7","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1172\/JCI29383","volume":"116","author":"TA Lagace","year":"2006","unstructured":"Lagace TA, Curtis DE, Garuti R, McNutt MC, Park SW, Prather HB, Anderson NN, Ho YK, Hammer RE, Horton JD: Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice. J Clin Invest. 2006, 116: 2995-3005. 10.1172\/JCI29383.","journal-title":"J Clin Invest"},{"key":"834_CR8","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.jacc.2013.07.056","volume":"62","author":"D Urban","year":"2013","unstructured":"Urban D, P\u00f6ss J, B\u00f6hm M, Laufs U: Targeting the Proprotein Convertase Subtilisin\/Kexin Type 9 for the Treatment of Dyslipidemia and Atherosclerosis. J Am Coll Cardiol. 2013, 62: 1401-1408. 10.1016\/j.jacc.2013.07.056.","journal-title":"J Am Coll Cardiol"},{"key":"834_CR9","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, INTERHEART Study Investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case\u2013control study. Lancet. 2004, 364: 937-952. 10.1016\/S0140-6736(04)17018-9.","journal-title":"Lancet"},{"key":"834_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.2174\/157340311799960690","volume":"7","author":"B Balci","year":"2011","unstructured":"Balci B: The modification of serum lipids after acute coronary syndrome and importance in clinical practice. Curr Cardiol Rev. 2011, 7: 272-276.","journal-title":"Curr Cardiol Rev"},{"key":"834_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2217\/clp.13.55","volume":"8","author":"J Liu","year":"2013","unstructured":"Liu J, Guo YL, Xu RX, Li JJ: Rapid effects of different lipid-lowering drugs on PCSK9 in humans. Clin Lipidol. 2013, 8: 519-524. 10.2217\/clp.13.55.","journal-title":"Clin Lipidol"},{"key":"834_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1194\/jlr.M000620","volume":"51","author":"JS Troutt","year":"2010","unstructured":"Troutt JS, Alborn WE, Cao G, Konrad RJ: Fenofibrate treatment increases human serum proprotein convertase subtilisin kexin type 9 levels. J Lipid Res. 2010, 51: 345-351. 10.1194\/jlr.M000620.","journal-title":"J Lipid Res"},{"key":"834_CR13","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1194\/jlr.P009860","volume":"51","author":"JD Browning","year":"2010","unstructured":"Browning JD, Horton JD: Fasting reduces plasma proprotein convertase, subtilisin\/kexin type 9 and cholesterol biosynthesis in humans. J Lipid Res. 2010, 51: 3359-3363. 10.1194\/jlr.P009860.","journal-title":"J Lipid Res"},{"key":"834_CR14","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.atherosclerosis.2010.09.027","volume":"213","author":"Q Cui","year":"2010","unstructured":"Cui Q, Ju X, Yang T, Zhang M, Tang W, Chen Q, Hu Y, Haas JV, Troutt JS, Pickard RT, Darling R, Konrad RJ, Zhou H, Cao G: Serum PCSK9 is associated with multiple metabolic factors in a large Han Chinese population. Atherosclerosis. 2010, 213: 632-636. 10.1016\/j.atherosclerosis.2010.09.027.","journal-title":"Atherosclerosis"},{"key":"834_CR15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cca.2011.09.023","volume":"413","author":"H Miyazawa","year":"2012","unstructured":"Miyazawa H, Honda T, Miyauchi S, Domon H, Okui T, Nakajima T, Tabeta K, Yamazaki K: Increased serum PCSK9 concentrations are associated with periodontal infection but do not correlate with LDL cholesterol concentration. Clin Chim Acta. 2012, 413: 154-159. 10.1016\/j.cca.2011.09.023.","journal-title":"Clin Chim Acta"},{"key":"834_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.bbrc.2008.07.023","volume":"374","author":"KR Feingold","year":"2008","unstructured":"Feingold KR, Moser AH, Shigenaga JK, Patzek SM, Grunfeld C: Inflammation stimulates the expression of PCSK9. Biochem Biophys Res Commun. 2008, 374: 341-344. 10.1016\/j.bbrc.2008.07.023.","journal-title":"Biochem Biophys Res Commun"},{"key":"834_CR17","doi-asserted-by":"publisher","first-page":"E732","DOI":"10.1210\/jc.2012-4236","volume":"98","author":"M Le Bras","year":"2013","unstructured":"Le Bras M, Roquilly A, Deckert V, Langhi C, Feuillet F, S\u00e9bille V, Mah\u00e9 PJ, Bach K, Masson D, Lagrost L, Costet P, Asehnoune K, Cariou B: Plasma PCSK9 is a late biomarker of severity in patients with severe trauma injury. J Clin Endocrinol Metab. 2013, 98: E732-E736. 10.1210\/jc.2012-4236.","journal-title":"J Clin Endocrinol Metab"},{"key":"834_CR18","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.jacc.2005.01.051","volume":"45","author":"SN Chen","year":"2005","unstructured":"Chen SN, Ballantyne CM, Gotto AM, Tan Y, Willerson JT, Marian AJ: A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis. J Am Coll Cardiol. 2005, 45: 1611-1619. 10.1016\/j.jacc.2005.01.051.","journal-title":"J Am Coll Cardiol"},{"key":"834_CR19","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1089\/hum.2007.036","volume":"18","author":"HF Duan","year":"2007","unstructured":"Duan HF, Wang H, Yi J, Liu HJ, Zhang QW, Li LB, Zhang T, Lu Y, Wu CT, Wang LS: Adenoviral gene transfer of sphingosine kinase 1 protects heart against ischemia\/reperfusion-induced injury and attenuates its postischemic failure. Hum Gene Ther. 2007, 18: 1119-1128. 10.1089\/hum.2007.036.","journal-title":"Hum Gene Ther"},{"key":"834_CR20","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s40261-013-0129-2","volume":"33","author":"YL Guo","year":"2013","unstructured":"Guo YL, Liu J, Xu RX, Zhu CG, Wu NQ, Jiang LX, Li JJ: Short-Term Impact of Low-Dose Atorvastatin on Serum Proprotein Convertase Subtilisin\/Kexin Type 9. Clin Drug Investig. 2013, 33: 877-883. 10.1007\/s40261-013-0129-2.","journal-title":"Clin Drug Investig"},{"key":"834_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1194\/jlr.M700443-JLR200","volume":"49","author":"HJ Jeong","year":"2008","unstructured":"Jeong HJ, Lee HS, Kim KS, Kim YK, Yoon D, Park SW: Sterol dependent regulation of proprotein convertase subtilisin\/kexin type 9 by sterol regulatory element binding-protein 2. J Lipid Res. 2008, 49: 399-409.","journal-title":"J Lipid Res"},{"key":"834_CR22","doi-asserted-by":"publisher","first-page":"28885","DOI":"10.1074\/jbc.M109.052407","volume":"284","author":"H Li","year":"2009","unstructured":"Li H, Dong B, Park SW, Lee HS, Chen W, Liu J: Hepatocyte nuclear factor 1 alpha plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine. J Biol Chem. 2009, 284: 28885-28895. 10.1074\/jbc.M109.052407.","journal-title":"J Biol Chem"},{"key":"834_CR23","first-page":"3568","volume":"124","author":"JJ Li","year":"2011","unstructured":"Li JJ: Inflammation in coronary artery diseases. Chin Med J (Engl). 2011, 124: 3568-3575.","journal-title":"Chin Med J (Engl)"},{"key":"834_CR24","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.2174\/138161212802481219","volume":"18","author":"R Klingenberg","year":"2012","unstructured":"Klingenberg R, Luscher TF: Inflammation in coronary artery disease and acute myocardial infarction - is the stage set for novel therapies?. Curr Pharm Des. 2012, 18: 4358-4369. 10.2174\/138161212802481219.","journal-title":"Curr Pharm Des"},{"key":"834_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1155\/MI.2005.385","volume":"2005","author":"F Blancke","year":"2005","unstructured":"Blancke F, Claeys MJ, Jorens P, Vermeiren G, Bosmans J, Wuyts FL, Vrints CJ: Systemic inflammation and reperfusion injury in patients with acute myocardial infarction. Mediat Inflamm. 2005, 2005: 385-389. 10.1155\/MI.2005.385.","journal-title":"Mediat Inflamm"},{"key":"834_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/00365510600931114","volume":"66","author":"MT Yavuz","year":"2006","unstructured":"Yavuz MT, Yavuz O, Yazici M, Guler S, Ozhan H, Albayrak S, Coskun A: Interaction between Chlamydia pneumoniae seropositivity, inflammation and risk factors for atherosclerosis inpatients with severe coronary stenosis. Scand J Clin Lab Invest. 2006, 66: 523-534. 10.1080\/00365510600931114.","journal-title":"Scand J Clin Lab Invest"},{"key":"834_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cccn.2004.08.019","volume":"352","author":"JJ Li","year":"2004","unstructured":"Li JJ, Wang HR, Huang CX, Xue JL, Li GS: Enhanced response of blood monocytes to C-reactive protein in patients with unstable angina. Clin Chim Acta. 2004, 352: 127-133.","journal-title":"Clin Chim Acta"},{"key":"834_CR28","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.hlc.2004.02.005","volume":"13","author":"JJ Li","year":"2004","unstructured":"Li JJ, Fang CH, Cheng MZ, Chen X, Lee SW: Activation of nuclear factor-\u0199B and correlation with elevated plasma C-reactive protein in patients with unstable angina. Heart Lung Circ. 2004, 13: 173-178. 10.1016\/j.hlc.2004.02.005.","journal-title":"Heart Lung Circ"},{"key":"834_CR29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3109\/00365513.2013.860619","volume":"74","author":"B Altun","year":"2014","unstructured":"Altun B, Turkon H, Tasolar H, Begg\u0131 H, Altun M, Tem\u0131z A, Gaz\u0131 E, Barutcu A, Bekler A, Colkesen Y: The relationship between high-sensitive troponin T, neutrophil lymphocyte ratio and SYNTAX Score. Scand J Clin Lab Invest. 2014, 74: 108-115. 10.3109\/00365513.2013.860619.","journal-title":"Scand J Clin Lab Invest"},{"key":"834_CR30","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1161\/01.CIR.0000090690.67322.51","volume":"108","author":"S Baldus","year":"2003","unstructured":"Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, M\u00fcnzel T, Simoons ML, Hamm CW, CAPTURE Investigators: Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation. 2003, 108: 1440-1445. 10.1161\/01.CIR.0000090690.67322.51.","journal-title":"Circulation"},{"key":"834_CR31","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jep.2013.09.044","volume":"150","author":"XY Zhu","year":"2013","unstructured":"Zhu XY, Zhang ZL, Li P, Liang WY, Feng XR, Liu ML: Shenyuan, an extract of American Ginseng and Corydalis Tuber formula, attenuates cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and oxidative stress in a porcine model of acute myocardial infarction. J Ethnopharmacol. 2013, 150: 672-681. 10.1016\/j.jep.2013.09.044.","journal-title":"J Ethnopharmacol"},{"key":"834_CR32","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1194\/jlr.M014118","volume":"52","author":"E Rousselet","year":"2011","unstructured":"Rousselet E, Marcinkiewicz J, Kriz J, Zhou A, Hatten ME, Prat A, Seidah NG: PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke. J Lipid Res. 2011, 52: 1383-1391. 10.1194\/jlr.M014118.","journal-title":"J Lipid Res"},{"key":"834_CR33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s11010-011-1028-6","volume":"359","author":"CY Wu","year":"2012","unstructured":"Wu CY, Tang ZH, Jiang L, Li XF, Jiang ZS, Liu LS: PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl\/Bax-caspase9-caspase3 pathway. Mol Cell Biochem. 2012, 359: 347-358. 10.1007\/s11010-011-1028-6.","journal-title":"Mol Cell Biochem"},{"key":"834_CR34","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","volume":"45","author":"W Khovidhunkit","year":"2004","unstructured":"Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C: Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res. 2004, 45: 1169-1196. 10.1194\/jlr.R300019-JLR200.","journal-title":"J Lipid Res"},{"key":"834_CR35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.atherosclerosis.2011.11.026","volume":"220","author":"N Ferri","year":"2012","unstructured":"Ferri N, Tibolla G, Pirillo A, Cipollone F, Mezzetti A, Pacia S, Corsini A, Catapano AL: Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels. Atherosclerosis. 2012, 220: 381-386. 10.1016\/j.atherosclerosis.2011.11.026.","journal-title":"Atherosclerosis"},{"key":"834_CR36","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1007\/s00259-011-1739-7","volume":"38","author":"V Berti","year":"2011","unstructured":"Berti V, Sciagr\u00e0 R, Acampa W, Ricci F, Cerisano G, Gallicchio R, Vigorito C, Pupi A, Cuocolo A: Relationship between infarct size and severity measured by gated SPECT and long-term left ventricular remodelling after acute myocardial infarction. Eur J Nucl Med Mol Imaging. 2011, 38: 1124-1131. 10.1007\/s00259-011-1739-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"834_CR37","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.amjcard.2012.10.037","volume":"111","author":"CM Ballantyne","year":"2013","unstructured":"Ballantyne CM, Pitt B, Loscalzo J, Cain VA, Raichlen JS: Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial). Am J Cardiol. 2013, 111: 506-509. 10.1016\/j.amjcard.2012.10.037.","journal-title":"Am J Cardiol"},{"key":"834_CR38","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.amjcard.2004.10.016","volume":"95","author":"J Ferri\u00e8res","year":"2005","unstructured":"Ferri\u00e8res J, Cambou JP, Gu\u00e9ret P, Boutalbi Y, Lablanche JM, Hanania G, Gen\u00e8s N, Cantet C, Danchin N: Effect of early initiation of statins on survival in patients with acute myocardial infarction (the USIC 2000 Registry). Am J Cardiol. 2005, 95: 486-489. 10.1016\/j.amjcard.2004.10.016.","journal-title":"Am J Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-14-192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2261-14-192\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-14-192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-14-192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T07:02:58Z","timestamp":1630566178000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/1471-2261-14-192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["834"],"URL":"https:\/\/doi.org\/10.1186\/1471-2261-14-192","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"12 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"192"}}